Delivery Order SPE2DX22D0049-SPE2D825FA9SP
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $30,169.08 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, which is not set-aside designated, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,662.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order was competitively awarded with...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,268.90 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, which was not set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,248.96 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,263.40 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion through December 2026. The award was made through competitive procedures with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,038.96 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 5, 2025, with an ultimate completion date of July 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,002.50 on August 4, 2025, to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle. The contract was...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $47,362.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 17, 2025, with an ultimate completion date of July 18, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work is to be performed at the company's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,173.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 20, 2025, with an ultimate completion date of August 21, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle running through December 2026 that serves as the company's primary vehicle...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,343.54 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FA9SPDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $17,219.85 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is being performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Through this contract structure, AmerisourceBergen Drug Corp serves customers including the Defense Health Agency and U.S. Coast Guard, supporting the broader Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 8/4/25 |